Paid Clinical Trials in Texas

Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in San Antonio +2 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07414836·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Wearable Photoplethysmography for Non-invasive Hydration Assessment

for Hydration Status

Sites in Plano & Frisco

Sponsor: PepsiCo Global R&D

Sex: All·Age: 18 - 45·Accepts healthy volunteers

Code: NCT07520344·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for TP53 Y220C Mutation

Drug: rezatapopt

Sites in Dallas, San Antonio +3 more locations

Sponsor: PMV Pharmaceuticals, Inc

Sex: All·Age: 18+

Code: NCT07372625·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

for Vulvar Adenocarcinoma

Sites in Irving +2 more locations

Sponsor: Avacta Life Sciences Ltd

Sex: All·Age: 18+

Code: NCT07454642·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for Advanced Solid Tumor, Adult

Sites in Austin +14 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Descartes-08 in Autoantibody Myositis

for Antisynthetase Syndrome

Sites in Austin +3 more locations

Sponsor: Cartesian Therapeutics

Sex: All·Age: 18+

Code: NCT07391605·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

for Advanced Solid Tumors

Sites in San Antonio, Galveston +2 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07360314·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Mirikizumab Solution (LY3074828) in Healthy Participants

for Healthy

Sites in Dallas, San Antonio +3 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07446101·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study of TAK-755 in Adults With Acute Ischemic Stroke

for Acute Ischemic Stroke

Sites in Dallas, Cypress +7 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07392450·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Houston, San Antonio +6 more locations

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for PIK3CA Mutations

Sites in Austin +10 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07383506·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

for Healthy

Drug: BI 3000202

1 location in San Antonio

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07486102·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

for Colorectal Anastomosis

Sites in Houston +8 more locations

Sponsor: Medtronic - MITG

Sex: All·Age: 18+

Code: NCT07351071·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

for Systematic Lupus Erythematosus

Drug: Enpatoran

Sites in Frisco, Humble +11 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18 - 75

Code: NCT07355218·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

for Colorectal Cancer

1 location in Dallas

Sponsor: Blue Earth Diagnostics

Sex: All·Age: 18 - 80

Code: NCT07432633·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Radiprodil in Participants With Hepatic Impairment

for Hepatic Impairment

Sites in San Antonio & DeSoto

Sponsor: GRIN Therapeutics, Inc.

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07457229·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

for Colorectal Cancer

Sites in San Antonio +9 more locations

Sponsor: Cartography Biosciences

Sex: All·Age: 18+

Code: NCT07321106·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for Primary Myelofibrosis (PMF)

Drug: Ruxolitinib

Sites in Houston +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07357727·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for Transthyretin Amyloidosis With Cardiomyopathy

Sites in Dallas +10 more locations

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07358078·Recruiting·Listed Jan 2026

Apply to this trial

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for Pulmonary Arterial Hypertension

Sites in Dallas +14 more locations

Sponsor: Inhibikase Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07365332·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

for FGFR2 Gene Fusion/Rearrangement

Drug: Lirafugratinib

Sites in Houston +7 more locations

Sponsor: Elevar Therapeutics

Sex: All·Age: 18+

Code: NCT07359820·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for Peripheral Artery Disease (PAD)

Sites in Plano, Amarillo +15 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07318610·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for Solid Tumors (Phase 1)

Sites in Houston +2 more locations

Sponsor: Adcendo ApS

Sex: All·Age: 18+

Code: NCT07362888·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

for Eczema Atopic Dermatitis

1 location in Irving

Sponsor: Turn Therapeutics

Sex: All·Age: 18 - 80

Code: NCT07355075·Phase 2, Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

for Venous Embolism of Lower Extremities (Diagnosis)

Sites in Plano +3 more locations

Sponsor: Medtronic Endovascular

Sex: All·Age: 22+

Code: NCT07335341·Recruiting·Listed Jan 2026

Apply to this trial

A Study of LY4515100 in Healthy Participants

for Healthy

1 location in Dallas

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07339722·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 1 Study of Navlimetostat Tablet Formulations

for Healthy Participants

Drug: Navlimetostat

Sites in Austin +1 more location

Sponsor: Bristol-Myers Squibb

Sex: Female·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07544628·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Dallas +3 more locations

Sponsor: AbbVie

Sex: All·Age: 6 Months - 17

Code: NCT07306832·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

for Common Warts (Verruca Vulgaris)

Sites in San Antonio +3 more locations

Sponsor: Verrica Pharmaceuticals Inc.

Sex: All·Age: 2+

Code: NCT07457918·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

for Advanced Relapsed or Refractory Germ Cell Tumours

Sites in Houston +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07306559·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

for Geographic Atrophy Secondary to Age-related Macular Degeneration

Sites in Dallas +3 more locations

Sponsor: Complement Therapeutics

Sex: All·Age: 55+

Code: NCT07392255·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for Pulmonary Hypertension

Sites in Houston +12 more locations

Sponsor: Pulmovant, Inc.

Sex: All·Age: 18 - 85

Code: NCT07333183·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

for Cancer

Sites in Temple, Forth Worth +6 more locations

Sponsor: Elephas

Sex: All·Age: 18+

Code: NCT07327489·Recruiting·Listed Jan 2026

Apply to this trial

MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients

for Sepsis

Sites in Austin +2 more locations

Sponsor: Health Discovery Labs

Sex: All·Age: 18 - 85

Code: NCT07362862·Recruiting·Listed Jan 2026

Apply to this trial

TOUCH® CMC 1 New Enrollment US Study

for Osteoarthritis Thumb

Sites in San Antonio +3 more locations

Sponsor: Keri Medical SA

Sex: All·Age: 22+

Code: NCT07405983·Recruiting·Listed Feb 2026

Apply to this trial

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

for Diarrhea

Sites in Prosper, Rosharon +8 more locations

Sponsor: Bausch Health Americas, Inc.

Sex: All·Age: 6 - 12

Code: NCT07285785·Phase 4·Recruiting·Listed Dec 2025

Apply to this trial

Intratumoral N17350 in Advanced Solid Tumors

for Neoplasms, Solid Tumor

Sites in Houston +4 more locations

Sponsor: Onchilles Pharma Inc

Sex: All·Age: 18+

Code: NCT07339176·Phase 1, Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

for Hepatic Insufficiency

Drug: Eloralintide

Sites in San Antonio +1 more location

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT07401862·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

for EGFR Mutation Positive Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Houston +5 more locations

Sponsor: Nuvectis Pharma, Inc.

Sex: All·Age: 18+

Code: NCT07315113·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for Lymphoma Diffuse Large B-cell

Sites in Houston +4 more locations

Sponsor: AvenCell Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284433·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial